Protalix Biotherapiutics
Protalix Biotherapiutics's email is bd@protalix.com
and
Protalix Biotherapiutics's phone number is 972-4-902-8100
.
Protalix is a biopharmaceutical company that is revolutionizing the development and manufacturing of recombinant therapeutic proteins through its ProCellEx® plant cell-based protein expression system. Using ProCellEx, Protalix is focused on the development and commercialization of a proprietary pipeline of novel and biosimilar proteins that target large, established pharmaceutical markets and that rely upon known biological mechanisms of action. Protalix’s initial commercial focus is on complex therapeutic proteins for the treatment of genetic disorders, such as Gaucher ...
read more
Protalix is a biopharmaceutical company that is revolutionizing the development and manufacturing of recombinant therapeutic proteins through its ProCellEx® plant cell-based protein expression system. Using ProCellEx, Protalix is focused on the development and commercialization of a proprietary pipeline of novel and biosimilar proteins that target large, established pharmaceutical markets and that rely upon known biological mechanisms of action. Protalix’s initial commercial focus is on complex therapeutic proteins for the treatment of genetic disorders, such as Gaucher disease and Fabry disease. Protalix is also advancing additional recombinant biopharmaceutical drug development programs, including a TNF inhibitor for inflammatory diseases. Protalix’s pipeline is led by ELELYSO™(taliglucerase alfa for injection), which received approval from the U.S. Food and Drug Administration on May 1, 2012. ELELYSO is the first FDA-approved plant cell-based recombinant therapeutic protein. Protalix has partnered with Pfizer for worldwide development and commercialization of ELELYSO, excluding Israel, where Protalix has retained full rights. Marketing applications for taliglucerase alfa have been submitted for Europe, Israel, Brazil and Australia, with additional regulatory submissions in progress.
show less
Website | protalix.com | |
Industry | Biotechnology | |
Employees | 142 | |
Founded | 1994 |
HQ | 2 Snunit St. Science Park, POB 455 | |
Phone | 972-4-902-8100 | |
bd@protalix.com | ||
Funding | 159,900,000 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | protalix.com | |
Industry | Biotechnology | |
Employees | 142 | |
Founded | 1994 | |
linkedin.com/company/protalix-biotherapiutics | ||
HQ | 2 Snunit St. Science Park, POB 455 | |
Phone | 972-4-902-8100 | |
bd@protalix.com | ||
Funding | 159,900,000 USD |
Email Patterns for Protalix Biotherapiutics
Top Competitors for Protalix Biotherapiutics
Protalix Biotherapiutics Questions
Where are Protalix Biotherapiutics's headquarters?
Protalix Biotherapiutics's headquarters are in 2 Snunit St. Science Park, POB 455
What is Protalix Biotherapiutics's phone number?
Protalix Biotherapiutics's phone number is 972-4-902-8100
What is Protalix Biotherapiutics's official website?
Protalix Biotherapiutics's website is protalix.com
How many employees are working in Protalix Biotherapiutics right now?
Protalix Biotherapiutics has
142 employees.
View the Email and Phone Numbers for all 142 working at Protalix Biotherapiutics.
What is Protalix Biotherapiutics's industry?
Protalix Biotherapiutics's industry is
Biotechnology
Who are Protalix Biotherapiutics's top competitors?
Protalix Biotherapiutics's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Protalix Biotherapiutics's email address?
Protalix Biotherapiutics's email address is bd@protalix.com
What are Protalix Biotherapiutics's categories?
Protalix Biotherapiutics's categories are Biotechnology, Manufacturing, Pharmaceutical, Therapeutics
When was Protalix Biotherapiutics's founded?
Protalix Biotherapiutics's founding year is 1994
What is Protalix Biotherapiutics's funding?
Protalix Biotherapiutics's funding is 159,900,000 USD
What is Protalix Biotherapiutics's current status?
Protalix Biotherapiutics's current status is ipo
Top Protalix Biotherapiutics Employees
Senior Director Clinical Operations
erez.gollan@merck.com
+97254-971-6012
Senior Director Of Projects And Validation
idoc@protalix.com
+1646-378-2927
Piorector Team Leader
inad.zenaty@protalix.com
+97252-302-7032
Vice President, Business Development
wtaylor@pfenex.com
+1314-614-7356
Analyst
alonbenda@gmail.com
Housekeeping
eyal.moshe@protalix.com
Production Staff